New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation
Babić, Ž.; Crkvenčić, M.; Rajić, Z.; Mikecin, A.-M.; Kralj, M.; Balzarini, J.; Petrova, M.; Vanderleyden, J.; Zorc, B. New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation. Molecules 2012, 17, 1124-1137. https://doi.org/10.3390/molecules17011124
Babić Ž, Crkvenčić M, Rajić Z, Mikecin A-M, Kralj M, Balzarini J, Petrova M, Vanderleyden J, Zorc B. New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation. Molecules. 2012; 17(1):1124-1137. https://doi.org/10.3390/molecules17011124
Chicago/Turabian StyleBabić, Željka, Maja Crkvenčić, Zrinka Rajić, Ana-Matea Mikecin, Marijeta Kralj, Jan Balzarini, Mariya Petrova, Jos Vanderleyden, and Branka Zorc. 2012. "New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation" Molecules 17, no. 1: 1124-1137. https://doi.org/10.3390/molecules17011124